Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2003
10/09/2003CA2480227A1 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003CA2479939A1 Immunosuppressant compounds, methods and uses related thereto
10/09/2003CA2479932A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003CA2479915A1 Co-beadlet of dha and rosemary and methods of use
10/09/2003CA2479744A1 Substituted 2,3-diphenyl pyridines
10/09/2003CA2479644A1 Imidazo fused compounds
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003CA2479495A1 Remedy for glioblastoma
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003CA2479110A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
10/09/2003CA2478389A1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003CA2477841A1 Method of use
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2477268A1 Compositions and compounds for use as molecular adjuvant for a nicotine vaccine
10/09/2003CA2476923A1 Method for treating cognitive disorders
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350104A2 Presenilin enhancers
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349918A1 Method of collecting placental stem cells
10/08/2003EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses
10/08/2003EP1349864A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
10/08/2003EP1349861A1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS
10/08/2003EP1349858A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
10/08/2003EP1349857A1 Purine derivatives as purinergic receptor antagonists
10/08/2003EP1349851A1 Compounds
10/08/2003EP1349850A1 Sodium channel modulators derived from 2-piperidylimidazoles
10/08/2003EP1349843A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003EP1349835A2 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo 3.1.0]hexane, compositions and uses thereof
10/08/2003EP1349577A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins
10/08/2003EP1349575A2 Compositions for stimulating cd45 and thereby suppressing microglial activation associated with alzheimer's disease
10/08/2003EP1349559A1 Compositions for inducing secretion of insulin-like growth factor-1
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
10/08/2003EP1349556A2 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages
10/08/2003EP1349552A1 Pyrazolo 3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists
10/08/2003EP1349550A1 Substituted-4-quinolones
10/08/2003EP1349546A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
10/08/2003EP1349541A1 Self emulsifying lipid matrix (selm)
10/08/2003EP1183014B1 Controlled release and taste masking oral pharmaceutical compositions
10/08/2003EP1181285B1 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
10/08/2003EP1140934B1 Benzisoxazoles and phenones as alpha-2-antagonists
10/08/2003EP1137398B1 Pharmaceutical preparation for inhalation of an opioid
10/08/2003EP1073455B1 Compositions and methods for extending the action of clostridial neurotoxin
10/08/2003EP0951284B1 Phenylethylamine derivatives
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/08/2003EP0929299B1 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA(b)BENZOFURANS
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003EP0920523B1 Hsv strain lacking functional icp27 and icp34.5 genes
10/08/2003EP0750628B1 Fibroblast growth factor-10
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003CN1447857A Agonist anti-TRK-C monoclonal antibodies
10/08/2003CN1447811A Medicinal compsns. and its use
10/08/2003CN1447810A Bicyclo-pyrazoles active as kinase inhibitors,process for their prepn. and pharmaceutical compsns. comprising them
10/08/2003CN1447809A Medicines for prevention and treatment of neurodegenerative diseases
10/08/2003CN1447807A Chromenone derivatives and their use for treating diseases in conjunction with 5-HT1A receptors and/or dopamine D2 receptors
10/08/2003CN1447806A 4-,5-,6-and 7-indole derivatives useful for treatment of CNS disorders
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447794A Novel compounds
10/08/2003CN1447793A Prodrugs to NMDA receptor ligands
10/08/2003CN1447792A Aporphine esters and their use in therapy
10/08/2003CN1447791A 10-aryl-11-hbenzo [b] fluorene derivatives and analogs for medicinal use
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1447693A Use of angiotensin Ôàí antagonists
10/08/2003CN1447691A Pharmaceutical combination of angiotensin Ôàí antagonists and ace inhibitors
10/08/2003CN1447687A Compsns. for improving mental concentration
10/08/2003CN1447684A Stable gabapentin having PH within controlled range
10/08/2003CN1446907A Method for proliferating and differentiating nerve stem cells under medication inducement and its application
10/08/2003CN1446813A Novel dihydric indole compound, their prepn. process and medicinal compsns. contg.them
10/08/2003CN1446585A Combination object of half solid framework preparation of gingko leaf extract product
10/08/2003CN1446584A Addition agent of pyrithioxine hydrochloride utilized for injection
10/08/2003CN1446581A Coupling object between CB and biological active peptide or immunoglobhulin or immunological activity original as well as medication usage
10/08/2003CN1446565A Medicine for treating senile dementia and preparation method
10/08/2003CN1446538A Aaalgesic prepared Chinese medicine with non-addiction and its preparing technique method
10/08/2003CN1446537A Freeze drying powder pins of methane-sulfonic acid dihydro elboline and its preparing method
10/08/2003CN1446536A Combination of semisolid framework preparation of nimodipine
10/08/2003CN1446535A Chlorhydric [R(2)-alpha-methoxyimindogen-alpha-(1-dicycloaza [2.2.2] caryl-3-group) acetonitrile control-released dosage form
10/08/2003CN1123571C 1-(3-heteroarylpropyl-or-prop-2-enyl)-4-benzylpiperidines used as NMDA receptor antagonists
10/08/2003CN1123360C Inhibitors of cyclophilin rotamase activity
10/08/2003CN1123359C Treatment of cerebral ischomia and cerebral damage with neuroprotective agent
10/08/2003CN1123343C Nicotine compsns. and method for formulation thereof
10/08/2003CN1123342C Use of inhibitors of renin-angiotension system
10/07/2003US6630573 Tau-conotoxin peptides
10/07/2003US6630514 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
10/07/2003US6630507 Cannabinoids as antioxidants and neuroprotectants
10/07/2003US6630505 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630500 Treating angiogenic disorders
10/07/2003US6630494 Treatment for central degenerative disorders, brain power disorders, depressions, and for prophylaxis of cerebral circulatory disorders
10/07/2003US6630493 Heterocyclically substituted amides, their preparation and use
10/07/2003US6630491 Use of nicotinic analogs for treatment of degenerative diseases of the nervous system
10/07/2003US6630487 Treatment of insulin resistance with growth hormone secretagogues
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003US6630483 Phenanthridine-N-oxides
10/07/2003US6630475 5-amino-pyrazolo-(4, 3-e)-1,2,4-triazolo(1,5-c)pyrimidine adenosine A2a receptor antagonists; use in the treatment of central nervous system diseases, in particular Parkinson's disease
10/07/2003US6630472 Compounds, pharmaceutical compositions, and methods for stimulating neuronal growth and elongation
10/07/2003US6630471 Central nervous system disorders
10/07/2003US6630469 5-HT7 receptor antagonists
1 ... 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 ... 1833